To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
May 2020

Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS

Vol: 9| Issue: 5| Number:13| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Radiotherapy alone with concurrent chemoradiotherapy plus temozolamide in locally advanced soft tissue sarcoma at Mayo Hospital Lahore: A randomized controlled trial.

JPMA 70: 572. 2020 Apr 1;1:3-1.

Contributing Authors:
MA Khokhar M Akhtar SFUHS Gillani R Abdulsalaam S Qamar

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-four patients with soft tissue sarcomas (STS) were randomized to receive radiation therapy only or radiation therapy plus oral temozolomide. The primary outcome of interest was treatment response as measured by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria. Secondary outcomes of interest included the incidence of adverse events. Results revealed a significantly higher i...

Join the Conversation

Please Login or Join to leave comments.